Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Risk factors for intensive care unit admission in patients with severe leptospirosis: a comparative study according to patients’ severity

  • Elizabeth De Francesco Daher1, 2,
  • Douglas Sousa Soares1,
  • Anna Tereza Bezerra de Menezes Fernandes1,
  • Marília Maria Vasconcelos Girão1,
  • Pedro Randal Sidrim1,
  • Eanes Delgado Barros Pereira1, 2,
  • Natalia Albuquerque Rocha3 and
  • Geraldo Bezerra da SilvaJr4Email author
BMC Infectious DiseasesBMC series – open, inclusive and trusted201616:40

https://doi.org/10.1186/s12879-016-1349-x

Received: 3 July 2015

Accepted: 13 January 2016

Published: 1 February 2016

Abstract

Background

The aim of this study is to investigate predictive factors for intensive care unit (ICU) admission among patients with severe leptospirosis.

Methods

This is a retrospective study with all patients with severe leptospirosis admitted to a tertiary hospital. Patients were divided in ICU and ward groups. Demographical, clinical and laboratory data of the groups were compared as well as acute kidney injury (AKI) severity, according to the RIFLE criteria (R = Risk, I = Injury, F = Failure, L = Loss, E = End-stage kidney disease).

Results

A total of 206 patients were included, 83 admitted to ICU and 123 to ward. Mean age was 36 ± 15.8 years, with 85.9 % males. Patients in ICU group were older (38.8 ± 15.7 vs. 34.16 ± 15.9 years, p = 0.037), had a shorter hospital stay (4.13 ± 3.1 vs. 9.5 ± 5.2 days, p = 0.0001), lower levels of hematocrit (29.6 ± 6.4 vs. 33.1 ± 8.6 %, p = 0.003), hemoglobin (10.2 ± 2.4 vs. 11.6 ± 1.9 g/dL, p < 0.0001), and platelets (94,427 ± 86,743 vs. 128,896 ± 137,017/mm3, p = 0.035), as well as higher levels of bilirubin (15.0 ± 12.2 vs. 8.6 ± 9.5 mg/dL, p = 0.001). ICU group also had a higher frequency of severe AKI (RIFLE-“Failure”: 73.2 % vs. 54.2 %, p < 0.0001) and a higher prevalence of dialysis requirement (57.3 % vs. 27.6 %, p < 0.0001). Mortality was higher among ICU patients (23.5 % vs. 5.7 %, p < 0.0001). Independent predictors for ICU admission were tachypnea (p = 0.027, OR = 13, CI = 1.3–132), hypotension (p = 0.009, OR = 5.27, CI = 1.5–18) and AKI (p = 0.029, OR = 14, CI = 1.3–150). Ceftriaxone use was a protective factor (p = 0.001, OR = 0.13, CI = 0.04–0.4).

Conclusions

Independent risk factors for ICU admission in leptospirosis include tachypnea, hypotension and AKI. Ceftriaxone was a protective factor for ICU admission, suggesting that its use may prevent severe forms of the disease.

Keywords

Leptospirosis Weil’s disease Acute kidney injury Intensive care unit Mortality

Background

Leptospirosis is one of the most important zoonosis in the world [1]. The disease may manifest as a broad spectrum of signs and symptoms, with a sudden onset of headache, high-degree fever, malaise, myalgia, conjunctival suffusion and transient rash [1]. The severe form is characterized by jaundice, acute kidney injury (AKI) and hemorrhage, particularly in the lungs, known as Weil’s disease [1, 2]. It is mainly caused by serovars Icterohaemorrhagiae, Copenhageni, Lai and others [1, 2]. Mortality from severe leptospirosis is high, ranging from 5 to 20 %, even when optimal treatment is provided3. Leptospirosis-associated AKI has peculiar characteristics: it is usually non-oliguric and associated with hypokalemia or normokalemia [1, 3, 4].

Intensive Care Unit (ICU) admission is often necessary for patients with severe leptospirosis. In a recent Brazilian study, leptospirosis was among the most frequent infectious diseases that required ICU [5]. Mortality rates remain high, despite of treatments instituted [3, 6]. It was demonstrated that early dialysis reduces mortality and complications associated with leptospirosis in the ICU [7].

Early identification of severe or potentially severe cases of leptospirosis, and then possible ICU admission need, is of crucial importance to enhance more aggressive treatment and decrease mortality, which is still unacceptable high in this disease. As leptospirosis is endemic in many tropical and developing countries, a more adequate classification and approach to patients can probably impact on economic issues. A mortality decrease in leptospirosis, for example, is favorable to labor, once great part of leptospirosis patients are young man, and it is possible to avoid years of life lost.

Hence, the aim of this study was to investigate predictive factors for ICU admission among patients with severe leptospirosis.

Methods

Studied population

The study included all patients with confirmed diagnosis of severe leptospirosis (Weil’s disease) consecutively admitted to São José Infectious Diseases Hospital, in Northeast Brazil, from 2000 to 2013. Study Design

This is a cross-sectional study. Data on hospital admission were obtained from medical records. They were initially admitted to the emergency department, and then transferred to another unit (ward or ICU). We also grouped these patients according to the site of care: those transferred to the ICU and to ward. A comparison of demographical, clinical and laboratory data between the two groups was performed in order to investigate differences between them and factors associated with ICU admission.

Case definition

Leptospirosis cases were defined as the presence of positive serology through microscopic agglutination test (MAT) higher than 1:800. All patients had also epidemiological and clinical history compatible with leptospirosis.

Inclusion criteria

Inclusion criteria were: patients ≥ 18 years-old, positive serology for leptospirosis, admission at São José Infectious Diseases Hospital during the study period.

Exclusion criteria

Exclusion criteria were: patients ≤ 18 years-old, negative serology for leptospirosis, incomplete data on medical records, referral to other hospitals and hospital stay less than 24 h.

Studied parameters

Demographic characteristics such as age, gender, time between initial symptoms and hospital admission as well as length of hospital stay were recorded. The clinical investigation included a record of all clinical signs and symptoms presented by each patient on hospital admission and during hospital stay, medications used, dialysis requirement and co-infections.

Laboratory data on hospital admission included an assessment of serum urea, creatinine, sodium, potassium, total bilirubin, direct bilirubin, indirect bilirubin, aspartate aminotransferase (AST), alanine aminotransferase (ALT), lactate dehydrogenase (LDH), hemoglobin, hematocrit, leukocyte count, platelets count and arterial blood gas analysis.

Definitions

Acute kidney injury (AKI) was defined according to RIFLE criteria (R = Risk, I = Injury, F = Failure, L = Loss, E = End-stage kidney disease) [8]. Thrombocytopenia was defined as platelets count lower than 150,000/mm3 and anemia as hemoglobin <12 g/dL. The occurrence of metabolic acidosis was considered when pH < 7.35 and HCO3 < 20 mEq/L, and severe metabolic acidosis when pH < 7.10. Tachypnea was defined as a respiratory rate higher than 25 per minute. Oliguria was defined as urine output < 400 ml/day after 24 h of effective hydration. Hypotension was defined as mean arterial blood pressure (MAP) < 60 mmHg, and therapy with vasoactive drugs was initiated when MAP remained lower than 60 mmHg despite the use of endovenous fluids. Hypertension was defined as systolic pressure ≥130 mmHg and/or diastolic pressure ≥85 mmHg.

Statistical analysis

The results were expressed through tables, mean ± standard deviation (SD). All data were analyzed with the program SPSS version 20.0 (Chicago, IL, USA). Comparison between the two groups was performed using Pearson’s Chi-square test and Student’s T test. Mann–Whitney test was used for parameters with a non-normal distribution. A logistic regression model was used for quantitative variables. Adjusted odds ratios (OR) and 95 % confidence intervals (CI) were calculated. A multivariate logistic regression was performed to analyze the possible risk factors associated with ICU admission. The parameters included in the multivariate model were those that showed a significance level in the univariate analysis. Significance level was set at 5 % (p values ≤ 0.05).

Ethics

The protocol of this study was approved by the Ethics Committee of São José Infectious Diseases Hospital, Fortaleza, Ceará, Brazil.

Results

Patients’ characteristics

Among 206 patients included in the study, eighty-three were included in the ICU group and 123 in the ward group. There was a predominance of males (85.9 %), and mean age was 36 ± 15.8 years. Complete evaluation of demographic data is presented in Table 1.
Table 1

Comparison of demographic data between patients with severe leptospirosis admitted to ICU and ward

 

ICU (N = 83)

Ward (N = 123)

p

Age (years)

38.8 ± 15.7

34.1 ± 15.9

0.037

Gender

 Male

72 (86.7 %)

105 (85.4 %)

0.840

 Female

11 (13.3 %)

18 (14.6 %)

 

Hospital stay (days)

4.13 ± 3.1

9.5 ± 5.2

0.0001

Time between onset of symptoms and hospitalization (days)

7 ± 4

7.22 ± 4.11

0.224

Mortality (%)

23.5

5.7

<0.0001

Pearson’s Chi-square test, T-Student test and Mann–Whitney test were used to perform this comparison. P values ≤ 0.05 were considered statistically significant

Signs and symptoms at admission

Main signs and symptoms at hospital admission were fever (87.1 %), myalgia (77.2 %), jaundice (71.7 %), headache (65.5 %), calf pain (48.5 %), asthenia (45.0 %) and diarrhea (41.5 %). Higher levels of heart and respiratory rates were observed in ICU group (105.0 ± 19.5 vs. 94.7 ± 19.0/min, p = 0.008; 31.8 ± 13.0 vs. 25.0 ± 8.8/min, p = 0.004, respectively), as well as lower levels of systolic blood pressure (106.3 ± 27 vs. 115.2 ± 18 mmHg, p = 0.018), as summarized in Table 2.
Table 2

Comparison of signs, symptoms and vital signs among patients with severe leptospirosis admitted to ICU and ward

 

ICU (N = 48)

Ward (N = 123)

p

Signs and symptoms

 Choluria

7 (16.6 %)

54 (44.7 %)

0.001

 Crackles

1 (2.1 %)

15 (13 %)

0.043

 Diarrhea

12 (25 %)

52 (42.3 %)

0.855

 Dyspnea

18 (37.5 %)

33 (27.6 %)

0.287

 Fever

33 (68.8 %)

115 (94.3 %)

<0.0001

 Hematemesis

7 (14.6 %)

7 (5.7 %)

0.068

 Hematuria

3 (8.3 %)

8 (7.3 %)

0.759

 Hemoptysis

8 (16.7 %)

9 (8.1 %)

0.625

 Jaundice

30 (64.5 %)

87 (71.5 %)

0.998

 Myalgia

27 (58.3 %)

104 (84.6 %)

<0.0001

 Oliguria

10 (22.9 %)

32 (26.8 %)

0.699

 Conjunctival suffusion

4 (10.4 %)

22 (17.9 %)

0.305

 Tachypnea

15 (33.3 %)

15 (13 %)

0.004

Vital signs

 SBP (mmHg)

106.28 ± 27

115.17 ± 18

0.018

 DBP (mmHg)

64.53 ± 18.7

71.3 ± 14.8

0.18

 HR (/min)

105.03 ± 19.5

94.7 ± 19.05

0.008

 RR (/min)

31.8 ± 13

25 ± 8.78

0.004

SBP systolic blood pressure, DBP diastolic blood pressure, HR Heart Rate, RR Respiratory Rate. Pearson’s Chi-squared test, T-Student test and Mann–Whitney test were used. P values ≤ 0.05 were considered statistically significant

Comparison between ICU and ward group

Patients in the ICU group were older than ward group (38.8 ± 15.7 vs. 34.2 ± 15.9 years, p = 0.037). Average length of hospital stay was shorter in the ICU group (4.13 ± 3.1 vs. 9.5 ± 5.2 days, p = 0.001). Patients admitted to ICU also presented lower levels of hematocrit (29.6 ± 6.4 vs. 33.1 ± 8.6 %, p = 0.003), hemoglobin (10.2 ± 2.4 vs. 11.6 ± 1.9 g/dL, p < 0.0001), platelets (94,427 ± 86,743 vs. 128,896 ± 137,017/mm3, p = 0.035), as well as higher levels of total bilirubin, direct and indirect bilirubin (15.0 ± 12.2 vs. 8.6 ± 9.5 mg/dL, p = 0.001; 9.2 ± 8.5 vs. 5.9 ± 7.1 mg/dL, p = 0.018; 4.5 ± 6.1 vs. 2.4 ± 3.2 mg/dL, p = 0.013, respectively) on hospital admission, as summarized in Table 3. ICU patients also presented higher prevalence of hypertension (68.0 vs. 43.9 %, p = 0.006), hypotension (66.0 vs. 33.3 %, p < 0.0001), metabolic acidosis (60.5 vs. 36.5 %, p = 0.011) and severe metabolic acidosis (11.0 vs. 0 %, p = 0.02) on hospital admission.
Table 3

Comparison of laboratory data between patients with severe leptospirosis admitted to ICU and wards

Parameters

ICU

Non-ICU

p

N = 83

N = 123

Creatinine (mg/dl)

3.97 ± 2.25

2.97 ± 2.4

0.004

Urea (mg/dl)

131.8 ± 68

101.2 ± 72.5

0.004

Potassium (mEq/L)

3.91 ± 0.85

3.9 ± 1.07

0.951

Sodium (mEq/L)

133 ± 6.61

130 ± 19

0.317

AST (UI/L)

169.8 ± 199

132.13 ± 183

0.285

ALT (UI/L)

101.83 ± 90

101.90 ± 153

0.998

LDH (UI/L)

810.25 ± 539

671.94 ± 420

0.416

Total bilirubin (mg/dl)

15 ± 12.2

8.6 ± 9.5

0.001

Direct bilirubin (mg/dl)

9.2 ± 8.5

5.9 ± 7.11

0.018

Indirect bilirubin (mg/dl)

4.48 ± 6.08

2.38 ± 3.22

0.013

Hematocrit (%)

29.6 ± 6.4

33.1 ± 8.63

0.003

Hemoglobin (g/dl)

10.2 ± 2.4

11.6 ± 1.95

<0.001

WBC (103/mm3)

14.30 ± 7.70

14.95 ± 1.82

0.772

Platelets (103/mm3)

94.42 ± 86.74

128.89 ± 137.01

0.035

pO2 (mmHg)

87.3 ± 32

83 ± 34

0.542

pCO2 (mmHg)

31.81 ± 9.4

32.64 ± 8.5

0.636

pH

7.35 ± 0.08

7.36 ± 0.07

0.127

Bicarbonate (mEq/L)

17.89 ± 4.82

18.8 ± 4.89

0.330

SaO2 (%)

93.82 ± 5.7

91.6 ± 10.17

0.190

AST aspartate aminotransferase, ALT alanine aminotransferase, LDH lactate dehydrogenase, WBC white blood cells, PO 2 O2 partial pressure, PCO 2 PCO2 partial pressure, SaO 2 O2 saturation

Chi-squared test, T-Student test and Mann–Whitney test were used to perform this comparison. Values expressed as mean ± SD and percentage. P values ≤ 0.05 were considered statistically significant

ICU group had higher levels of serum creatinine (3.97 ± 2.25 vs. 2.97 ± 2.4 mg/dL, p = 0.004) and serum urea (131.8 ± 68 vs. 101.2 ± 72.5 mg/dL, p = 0.004) on hospital admission. Oliguria was not significantly different between ICU group and ward group (22.9 % v. 26.8 %, p = 0.699, respectively). The ICU group also presented higher prevalence of AKI (93.9 % vs. 69.9 %, p < 0.0001), with a higher number of severe forms according to RIFLE criteria (“Risk” 4.9 % vs. 7.5 %, “Injury” 17.1 % vs. 10.0 % e “Failure” 73.2 % vs. 54.2 %, p < 0.0001). Need of dialysis was more frequent in this group (57.3 % vs. 27.6 %, p < 0.0001) when compared to ward group, as presented in Table 4.
Table 4

Comparison of acute kidney injury and dialysis requirement between patients with severe leptospirosis admitted to ICU and wards

 

ICU (N = 83)

Ward (N = 123)

p

AKI

77 (93.9 %)

85 (69.9 %)

<0.0001

Dialysis

47 (57.3 %)

33 (27.6 %)

<0.0001

RIFLE

 Risk

3 (4.9 %)

9 (7.5 %)

 

 Injury

14 (17.1 %)

12 (10 %)

<0.0001

 Failure

60 (73.2 %)

66 (54.2 %)

 

Chi-square test was performed to make this comparison. P values ≤ 0.05 were considered statistically significant

Treatment

Need of vasoconstrictors and use of diuretics were higher in ICU group (57.8 vs. 12.3 %, p < 0.0001; 49.4 vs. 26.1 %, p = 0.006, respectively). Ceftriaxone use was significantly higher in the ward group (67.6 vs. 41 %, p = 0.009), while the use of crystalline penicillin was similar in both groups, as summarized in Table 5.
Table 5

Comparison of treatments instituted for patients with severe leptospirosis admitted to ICU and ward

 

ICU (N = 83)

Ward (N = 123)

p

Hemoderivatives

44 (54 %)

58 (47.7 %)

0.052

Vasoconstrictors

47 (57.8 %)

15 (12.3 %)

<0.0001

Ceftriaxone

34 (41 %)

83 (67.6 %)

0.009

Penicillin

48 (59 %)

60 (49.1 %)

0.354

Diuretics

41 (49.4 %)

32 (26.1 %)

0.006

Pearson’s Chi-squared test was used to make the comparison. P values ≤ 0.05 were considered statistically significant

Risk factors for ICU admission

In multivariate analysis, independent predictors for ICU admission were: tachypnea (p = 0.027, OR: 13, CI = 1.3 - 132), hypotension (p = 0.009, OR: 5.27, CI = 1.5 - 18) and AKI severity (p = 0.029, OR: 14, CI = 1.3 - 150). On the other hand, ceftriaxone use was a protective factor (p = 0.001, OR = 0.13, CI = 0.04 – 0.4) for ICU admission, as described in Table 6.
Table 6

Independent risk factors for ICU admission among patients with severe leptospirosis (multivariate analysis)

Multivariate analysis

p

OR/ 95 % CI

Tachypnea

0.027

13 (1.3 – 132)

Hypotension

0.009

5.27 (1.5 – 18)

AKI

0.029

14 (1.3 – 150)

Ceftriaxone

0.001

0.13 (0.04-0.4)

OR odds ratio. 95 % CI: 95 % confidence interval. Logistic regression and multivariate analysis were performed to make this comparison. P values ≤ 0.05 were considered statistically significant

Mortality

Overall mortality was 12.7 %, and it was higher in ICU group (23.5 vs. 5.7 %, p < 0.0001).

Discussion

Predictors for ICU admission among patients with severe leptospirosis include tachypnea, hypotension and severe AKI, which can be identified at hospital admission and then subside requirement for a more aggressive treatment. The use of ceftriaxone was a protective factor against ICU admission, which suggests an important effect on decreasing disease severity.

Leptospirosis is a public health problem, with higher prevalence in tropical areas, including Brazil [4, 9]. The disease can present with severe manifestations and high mortality. Therefore it is important to characterize predictors of intensive care need in order to early identify potentially fatal cases and to provide a more careful approach. This is the first study in our region to investigate the differences between patients with leptospirosis admitted to a ward service and ICU.

In the present study patients admitted to the ICU were older, which may reflect an association between advanced age and disease severity, as previously reported [1012]. In a recent study from India, older age was a predictor of mortality in leptospirosis [3]. Leptospirosis in elderly patients was associated with severe course and increased risk of mortality, mostly due to the high incidence of comorbidities in this population [12].

The length of hospital stay was shorter in ICU patients, and this is probably due to a high mortality in cases that demand intensive care. We observed that more critically ill patients usually died during the first days of ICU admission, despite early treatment. Previous studies have shown that early daily dialysis in patients with leptospirosis-associated AKI reduces mortality and, therefore, it would probably be beneficial in critically ill patients [7, 13].

In the present study, ICU patients presented higher levels of total, direct and indirect bilirubin than ward patients. In a French study with leptospirosis patients, bilirubinemia was higher in severe cases and jaundice was demonstrated to be a predictive factor of severity in leptospirosis according to multivariate analysis (p = 0.005, OR = 10.1, CI = 1.79 – 56.8) [14]. In this same study, dyspnea (respiratory rate > 24/min) was higher in severe cases (p < 0.0001). These findings confirm the data in our study and reinforce the role of tachypnea as independent predictor for ICU admission, according to multivariate analysis.

We have found higher prevalence of anemia and thrombocytopenia as well as higher levels of urea and creatinine in the ICU group. Thrombocytopenia is frequent in leptospirosis and contributes to hemorrhagic phenomena [2, 15]. Although rare, pancytopenia can also be found in leptospirosis’ patients [16], but when it occurs other diagnosis must be investigated, such as hematologic disorders and visceral leishmaniasis, especially in tropical countries. In a recent study conducted in our region with 374 leptospirosis patients, thrombocytopenia was found in 53.5 % of patients on admission and it was associated with length of disease and AKI, but it was not associated with higher mortality [15].

Oliguria is a frequent feature in patients with severe AKI and it is associated with more frequent pulmonary involvement and higher mortality in leptospirosis [2, 13, 1720]. However, in the present study, oliguria was not associated with ICU admission, since there was no significant difference in frequency of oliguria between the two groups. Several hemodynamic changes that occur in leptospirosis, such as systemic vasodilation, renal vasoconstriction and elevation of aldosterone, associated with dehydration secondary to fever, vomiting and diarrhea could explain the onset of oliguria in leptospirosis patients [4, 21].

Hypotension was found to be a predictor of ICU admission in our study, according to multivariate analysis. Hemodynamic changes, such as increased vascular permeability secondary to cytokines and vasoactive mediators might also explain the onset of hypotension in severe cases. Low mean arterial pressure is well described as an important factor for the onset of AKI and disease severity in leptospirosis patients [22].

It is known that AKI severity in leptospirosis is associated with higher mortality [17, 23]. RIFLE and AKIN are good markers for the purpose of stratifying patients’ severity in leptospirosis. Worse AKI stages (RIFLE-F and AKIN-3) are associated with higher mortality [17]. In the present study, AKI RIFLE “Failure” was significantly higher in the ICU group.

The most recognized factors correlating with severity in leptospirosis are AKI, pulmonary involvement and electrolyte imbalances [24]. In the present study, independent risk factors associated with ICU admission were hypotension, tachypnea and AKI severity. In a recent study with 176 leptospirosis patients, independent predictors of severity were current cigarette smoking (OR  =  2.94 [CI 1.45-5.96]), delay >2 days between the onset of symptoms and the initiation of antibiotic therapy (OR  =  2.78 [CI 1.31-5.91]) and Leptospira interrogans serogroup Icterohaemorrhagiae as the infecting strain (OR  =  2.79 [CI 1.26-6.18]) [25]. Another study, conducted with 101 leptospirosis patients in India, showed that older age, delayed antibiotic therapy, higher bilirubin, aspartate aminotransferase, alkaline phosphatase, leucocyte count and aspartate/alanine aminotransferase ratio (AAR) were univariate predictors of mortality.

Ceftriaxone use was more frequent among patients admitted to ward and it was shown to be a protective factor for ICU admission, different from penicillin use, which was not different between groups. The use of antibiotics in leptospirosis has been widely debated. Numerous studies have been conducted to investigate the role of antibiotics in leptospirosis, with controversial results, and the current consensus is that antibiotics must be used, since it probably brings more benefits than harm, reducing the time of hospital stay, the duration of fever and slowing disease symptoms in general [2630]. It is possible that antibiotics have an important role in immune response modulation in leptospirosis, which could partially explain the observation of a better evolution in patients treated with penicillin [3133]. Nonetheless, mortality does not seem to be significantly influenced by antibiotic use [34].

As expected, in the present study, mortality was higher among ICU patients (23.5 % vs. 5.7 %, p < 0.0001) when compared to ward group. Some studies performed in our region have found mortality rates varying from 12 to 20 % in leptospirosis, which were lower than those found in the present study [35]. Even higher mortality rates have been described in some cases. In a study performed with 60 leptospirosis ICU patients between 2002 and 2003, mortality was 52 %, which was remarkably higher than average mortality in that ICU in the period [36]. These data reinforce the importance of determining predictors of ICU admission in leptospirosis.

Conclusion

Tachypnea, hypotension and AKI are risk factors for ICU admission, and ceftriaxone use is a protective factor. These results alert to early identification of the above mentioned factors and then a more aggressive treatment, including early antibiotics use and renal replacement therapy when needed to possibly decrease mortality.

Study limitations

Main limitations of this study derive from its retrospective nature. Some data from patient’s records were not available on admission. Urine output and urinalysis were particularly poorly available in the ward group, since non-critical care units frequently do not accurately measure and analyze urine output. Further prospective studies are then necessary to continue the investigation of leptospirosis predictors of ICU admission.

Abbreviations

AKI: 

Acute kidney injury

ALT: 

Alanine aminotransferase

AST: 

Aspartate aminotransferase

ICU: 

Intensive care unit

LDH: 

Lactate dehydrogenase

OI: 

Odds ratio

MAP: 

Mean arterial blood pressure

MAT: 

Microscopic agglutination test

OR: 

Odds ratio

RIFLE: 

Acrony for Risk, Injury, Failure, Loss, End-stage renal disease

SPSS: 

Statistic package for social science

Declarations

Acknowledgements

We are very grateful to the team of physicians, residents, medical students and nurses from the São José Infectious Diseases Hospital for the assistance provided to the patients and for the technical support provided to the development of this research. We also thank Dr. Ana Patricia Freitas Vieira for supporting in data collection. This study was supported by the Brazilian Research Council – Conselho Nacional de Desenvolvimento Científico e Tecnológico, CNPq (MCT/SCTIE/DECIT/MS/CNPq) and by the Edson Queiroz Foundation/University of Fortaleza.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Departament of Internal Medicine, School of Medicine, Division of Nephrology, Federal University of Ceará
(2)
Medical Sciences Graduate Program, School of Medicine, Federal University of Ceará
(3)
Department of Medicine, University of Texas Southwestern Medical Center
(4)
Public Health Graduate Program, School of Medicine, Health Sciences Center, University of Fortaleza

References

  1. Adler B, de la Peña Moctezuma A. Leptospira and leptospirosis. Vet Microbiol. 2010;140:287–96.View ArticlePubMedGoogle Scholar
  2. Bharti AR, Nally JE, Ricaldi JN, Matthias MA, Diaz MM, Lovett MA, et al. Leptospirosis: a zoonotic disease of global importance. Lancet Infect Dis. 2003;3:757–71.View ArticlePubMedGoogle Scholar
  3. Goswami RP, Goswami RP, Basu A, Tripathi SK, Chakrabarti S, Chattopadhyay I. Predictors of mortality in leptospirosis: an observational study from two hospitals in Kolkata, eastern India. Trans R Soc Trop Med Hyg. 2014;108:791–6.View ArticlePubMedGoogle Scholar
  4. Daher EF, Abreu KLS, Silva Junior GB. Leptospirosis-associated acute kidney injury. J Bras Nefrol. 2010;32:400–7.View ArticleGoogle Scholar
  5. Daher EF, Silva Junior GB, Vieira APF, Souza JB, Falcão FS, Costa CR, et al. Acute kidney injury in a tropical country: a cohort study of 253 patients in an infectious diseases intensive care unit. Rev Soc Bras Med Trop. 2014;47:86–9.View ArticleGoogle Scholar
  6. Daher EF, Vieira AP, Jacinto CN, Lima RS, Girão MM, Fernandes AT. Differences among children, adolescentes and adults with severe leptospirosis: a comparative analysis. Indian J Nephrol. 2014;24:166–70.View ArticlePubMed CentralPubMedGoogle Scholar
  7. Andrade L, Cleto S, Seguro AC. Door-to-dialysis time and daily hemodialysis in patients with leptospirosis: impact on mortality. Clin J Am Soc Nephrol. 2007;2:739–44.View ArticlePubMedGoogle Scholar
  8. Kellum JA, Bellomo R, Ronco C. Definition and classification of acute kidney injury. Nephron Clin Pract. 2008;109:c182–7.View ArticlePubMedGoogle Scholar
  9. Slack A. Leptospirosis. Aust Fam Physician. 2010;39:495–8.PubMedGoogle Scholar
  10. Rajapakse S, Rodrigo C, Haniffa R. Developing a clinically relevant classification to predict mortality in severe leptospirosis. J Emerg Trauma Shock. 2010;3:213–9.View ArticlePubMed CentralPubMedGoogle Scholar
  11. Guerrier G, Hie P, Gourinat AC, Huguon E, Polfrit Y, Goarant C, et al. Association between age and severity to leptospirosis in children. PLoS Negl Trop Dis. 2013;7:e2436.View ArticlePubMed CentralPubMedGoogle Scholar
  12. Gancheva GI. Leptospirosis in elderly patients. Braz J Infect Dis. 2013;17:592–5.View ArticlePubMedGoogle Scholar
  13. Cerqueira TB, Athanazio DA, Spichler AS, Seguro AC. Renal involvement in leptospirosis – new insights into pathophysiology and treatment. Braz J Infect Dis. 2008;12:248–52.View ArticlePubMedGoogle Scholar
  14. Abgueguen P, Delbos V, Blanvillain J, Chennebault JM, Cottin J, Fanello S, et al. Clinical aspects and prognostic factors of leptospirosis in adults. J Infect. 2008;57:171–8.View ArticlePubMedGoogle Scholar
  15. Daher EF, Silva Junior GB, Silveira CO, Falcão FS, Alves MP, Mota JA, et al. Factors associated with thrombocytopenia in severe leptospirosis (Weil’s disease). Clinics (São Paulo). 2014;69:106–10.View ArticleGoogle Scholar
  16. Stefos A, Georgiadou SP, Gioti C, Loukopoulos A, Ioannou M, Pournaras S, et al. Leptospirosis and pancytopenia: two case reports and review of the literature. J Infect. 2005;51:e277–80.View ArticlePubMedGoogle Scholar
  17. Silva Junior GB, Abreu KLS, Mota RMS, Barreto AGD, Araújo SMHA, Rocha HAL, et al. RIFLE and acute kidney injury network classifications predict mortality in leptospirosis-associated acute kidney injury. Nephrology (Carlton). 2011;16:269–76.View ArticleGoogle Scholar
  18. Uchino S, Bellomo R, Goldsmith D, Bates S, Ronco C. An assessment of the RIFLE criteria for acute renal failure in hospitalized patients. Crit Care Med. 2006;34:1913–7.View ArticlePubMedGoogle Scholar
  19. Spichler AS, Vilaça PJ, Athanazio DA, Albuquerque JO, Buzzar M, Castro B, et al. Predictors of lethality in severe leptospirosis in urban Brazil. Am J Trop Med Hyg. 2008;79:911–4.PubMed CentralPubMedGoogle Scholar
  20. Daher EF, Silva Junior GB, Karbage NNN, Carvalho Junior PC, Kataoka RS, et al. Predictors of oliguric acute kidney injury in leptospirosis: a retrospective study on 196 consecutive patients. Nephron Clin Pract. 2009;112:c25–30.View ArticlePubMedGoogle Scholar
  21. Visith S, Kearkiat P. Nephropathy in leptospirosis. J Postgrad Med. 2005;51:184–8.PubMedGoogle Scholar
  22. Niwattayakul K, Homvijitkul J, Khow O, Sitprija V. Leptospirosis in northeastern Thailand: hypotension and complications. Southeast Asian J Trop Med Public Health. 2002;33:155–60.PubMedGoogle Scholar
  23. Seguro AC, Andrade L. Pathophysiology of leptospirosis. Shock. 2013;39 Suppl 1:17–23.View ArticlePubMedGoogle Scholar
  24. Helmerhorst HJ, van Tol EM, Tuinman PR, de Vries PJ, Hartskeerl RA, Grobusch MP, et al. Severe pulmonary manifestation of leptospirosis. Neth J Med. 2012;70:215–21.PubMedGoogle Scholar
  25. Tubiana S, Mikulski M, Becam J, Lacassin F, Lefèvre P, Gourinat AC, et al. Risk factors and predictors of severe leptospirosis in New Caledonia. PLoS Negl Trop Dis. 2013;7:e1991.View ArticlePubMed CentralPubMedGoogle Scholar
  26. Daher EF, Nogueira CB. Evaluation of penicillin therapy in patients with leptospirosis and acute renal failure. Rev Inst Med Trop Sao Paulo. 2000;42:327–32.View ArticlePubMedGoogle Scholar
  27. Panaphut T, Domrongkithaporn S, Vibhagool A, Thinkamrop B, Susanengrat W. Ceftriaxone compared with sodium penicillin G for treatment of severe leptospirosis. Clin Infect Dis. 2003;36:1507–13.View ArticlePubMedGoogle Scholar
  28. Raptis L, Pappas G, Akritidis N. Use of ceftriaxone in patients with severe leptospirosis. Int J Antimicrob Agents. 2006;28:259–61.View ArticlePubMedGoogle Scholar
  29. Griffith ME, Hospenthal DR, Murray CK. Antimicrobial therapy of leptospirosis. Curr Opin Infect Dis. 2006;19:533–7.View ArticlePubMedGoogle Scholar
  30. Daher EF, Silva Junior GB, Abreu KLS, Mota RMS, Batista DV, Rocha NA, et al. Leptospirosis-associated acute kidney injury: penicillin at the late stage is still controversial. J Clin Pharm Ther. 2012;37:420–5.View ArticlePubMedGoogle Scholar
  31. Ziegeler S, Raddatz A, Hoff G, Buchinger H, Bauer I, Stockhausen A, et al. Antibiotics modulate the stimulated cytokine response to endotoxin in a human ex vivo, in vitro model. Acta Anaesthesiol Scand. 2006;50:1103–10.View ArticlePubMedGoogle Scholar
  32. Cetin BD, Harmankaya O, Hasman H, Gunduz A, Okar M, Seber E. Acute renal failure: a common manifestation of leptospirosis. Ren Fail. 2004;26:655–61.View ArticlePubMedGoogle Scholar
  33. Shah I. Non-oliguric renal failure - a presentation of leptospirosis. Ann Trop Med Parasitol. 2009;103:53–6.View ArticlePubMedGoogle Scholar
  34. Costa E, Lopes AA, Sacramento E, Costa YA, Matos ED, Lopes MB, et al. Penicillin at the late stage of leptospirosis: a randomized controlled trial. Rev Inst Med Trop Sao Paulo. 2003;45:141–5.View ArticlePubMedGoogle Scholar
  35. Daher EF, Silva Jr GB, Lima RS, Mota RM, Rocha HA, de Abreu KL, et al. Different patterns in a cohort of patients with severe leptospirosis (Weil syndrome): effects of an educational program in an endemic area. Am J Trop Med Hyg. 2011;85:479–84.View ArticlePubMed CentralPubMedGoogle Scholar
  36. Chawla V, Trivedi TH, Yeolekar ME. Epidemic of leptospirosis: an ICU experience. J Assoc Physicians India. 2004;52:619–22.PubMedGoogle Scholar

Copyright

© De Francesco Daher et al. 2016

Advertisement